Recombinant rabies virus with the glycoprotein fused with a DC-binding peptide is an efficacious rabies vaccine

Our previous studies demonstrated that recruiting and/or activating dendritic cells (DCs) enhanced the immunogenicity of recombinant rabies viruses (rRABV). In this study, rRABV LBNSE with a small DC-binding peptide (designated as rLBNSE-DCBp) or a negative control peptide (designated as rLBNSE-DCCp...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yachun, Zhou, Ming, Li, Yingying, Luo, Zhaochen, Chen, Huanchun, Cui, Min, Fu, Zhen F., Zhao, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787516/
https://www.ncbi.nlm.nih.gov/pubmed/29416659
http://dx.doi.org/10.18632/oncotarget.23160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787516/
https://www.ncbi.nlm.nih.gov/pubmed/29416659
http://dx.doi.org/10.18632/oncotarget.23160

Ejemplares similares